These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 28220810)
1. Dengue virus NS1 protein activates immune cells via TLR4 but not TLR2 or TLR6. Modhiran N; Watterson D; Blumenthal A; Baxter AG; Young PR; Stacey KJ Immunol Cell Biol; 2017 May; 95(5):491-495. PubMed ID: 28220810 [TBL] [Abstract][Full Text] [Related]
2. Dengue virus nonstructural protein 1 activates platelets via Toll-like receptor 4, leading to thrombocytopenia and hemorrhage. Chao CH; Wu WC; Lai YC; Tsai PJ; Perng GC; Lin YS; Yeh TM PLoS Pathog; 2019 Apr; 15(4):e1007625. PubMed ID: 31009511 [TBL] [Abstract][Full Text] [Related]
3. Activation of TLR2 and TLR6 by Dengue NS1 Protein and Its Implications in the Immunopathogenesis of Dengue Virus Infection. Chen J; Ng MM; Chu JJ PLoS Pathog; 2015 Jul; 11(7):e1005053. PubMed ID: 26226614 [TBL] [Abstract][Full Text] [Related]
4. Dengue virus NS1 protein activates cells via Toll-like receptor 4 and disrupts endothelial cell monolayer integrity. Modhiran N; Watterson D; Muller DA; Panetta AK; Sester DP; Liu L; Hume DA; Stacey KJ; Young PR Sci Transl Med; 2015 Sep; 7(304):304ra142. PubMed ID: 26355031 [TBL] [Abstract][Full Text] [Related]
5. Dengue virus NS1 cytokine-independent vascular leak is dependent on endothelial glycocalyx components. Glasner DR; Ratnasiri K; Puerta-Guardo H; Espinosa DA; Beatty PR; Harris E PLoS Pathog; 2017 Nov; 13(11):e1006673. PubMed ID: 29121099 [TBL] [Abstract][Full Text] [Related]
6. Synergism of toll-like receptor 2 (TLR2), TLR4, and TLR6 ligation on the production of tumor necrosis factor (TNF)-alpha in a spontaneous arthritis animal model of interleukin (IL)-1 receptor antagonist-deficient mice. Jung YO; Cho ML; Lee SY; Oh HJ; Park JS; Park MK; Park MJ; Ju JH; Kim SI; Park SH; Kim HY; Min JK Immunol Lett; 2009 Apr; 123(2):138-43. PubMed ID: 19428561 [TBL] [Abstract][Full Text] [Related]
7. Comment on "Dengue virus NS1 protein activates cells via Toll-like receptor 4 and disrupts endothelial cell monolayer integrity" and "Dengue virus NS1 triggers endothelial permeability and vascular leak that is prevented by NS1 vaccination". Halstead SB Sci Transl Med; 2015 Dec; 7(318):318le4. PubMed ID: 26676605 [TBL] [Abstract][Full Text] [Related]
8. Plugging the Leak in Dengue Shock. Watterson D; Modhiran N; Muller DA; Stacey KJ; Young PR Adv Exp Med Biol; 2018; 1062():89-106. PubMed ID: 29845527 [TBL] [Abstract][Full Text] [Related]
9. Response to comment on "Dengue virus NS1 protein activates cells via Toll-like receptor 4 and disrupts endothelial cell monolayer integrity" and "Dengue virus NS1 triggers endothelial permeability and vascular leak that is prevented by NS1 vaccination". Stacey KJ; Watterson D; Modhiran N; Young PR Sci Transl Med; 2015 Dec; 7(318):318lr4. PubMed ID: 26676606 [TBL] [Abstract][Full Text] [Related]
10. Polyclonal antibodies against properly folded Dengue virus NS1 protein expressed in E. coli enable sensitive and early dengue diagnosis. Allonso D; da Silva Rosa M; Coelho DR; da Costa SM; Nogueira RM; Bozza FA; Santos FB; de Barcelos Alves AM; Mohana-Borges R J Virol Methods; 2011 Jul; 175(1):109-16. PubMed ID: 21569796 [TBL] [Abstract][Full Text] [Related]
11. Development and characterization of mouse monoclonal antibodies against monomeric dengue virus non-structural glycoprotein 1 (NS1). Gelanew T; Poole-Smith BK; Hunsperger E J Virol Methods; 2015 Sep; 222():214-23. PubMed ID: 26070890 [TBL] [Abstract][Full Text] [Related]
12. Anti-dengue virus nonstructural protein 1 antibodies contribute to platelet phagocytosis by macrophages. Wan SW; Yang YW; Chu YT; Lin CF; Chang CP; Yeh TM; Anderson R; Lin YS Thromb Haemost; 2016 Mar; 115(3):646-56. PubMed ID: 26632672 [TBL] [Abstract][Full Text] [Related]
13. Dengue Virus Nonstructural Protein 1 Induces Vascular Leakage through Macrophage Migration Inhibitory Factor and Autophagy. Chen HR; Chuang YC; Lin YS; Liu HS; Liu CC; Perng GC; Yeh TM PLoS Negl Trop Dis; 2016 Jul; 10(7):e0004828. PubMed ID: 27409803 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic Effects of Monoclonal Antibody against Dengue Virus NS1 in a STAT1 Knockout Mouse Model of Dengue Infection. Wan SW; Chen PW; Chen CY; Lai YC; Chu YT; Hung CY; Lee H; Wu HF; Chuang YC; Lin J; Chang CP; Wang S; Liu CC; Ho TS; Lin CF; Lee CK; Wu-Hsieh BA; Anderson R; Yeh TM; Lin YS J Immunol; 2017 Oct; 199(8):2834-2844. PubMed ID: 28904127 [TBL] [Abstract][Full Text] [Related]
15. Dengue virus NS1 triggers endothelial permeability and vascular leak that is prevented by NS1 vaccination. Beatty PR; Puerta-Guardo H; Killingbeck SS; Glasner DR; Hopkins K; Harris E Sci Transl Med; 2015 Sep; 7(304):304ra141. PubMed ID: 26355030 [TBL] [Abstract][Full Text] [Related]
16. Development and characterization of serotype-specific monoclonal antibodies against the dengue virus-4 (DENV-4) non-structural protein (NS1). Gelanew T; Hunsperger E Virol J; 2018 Feb; 15(1):30. PubMed ID: 29409531 [TBL] [Abstract][Full Text] [Related]
17. Cyclic Dinucleotide-Adjuvanted Dengue Virus Nonstructural Protein 1 Induces Protective Antibody and T Cell Responses. Espinosa DA; Beatty PR; Reiner GL; Sivick KE; Hix Glickman L; Dubensky TW; Harris E J Immunol; 2019 Feb; 202(4):1153-1162. PubMed ID: 30642979 [TBL] [Abstract][Full Text] [Related]
18. Cell membrane-bound toll-like receptor-1/2/4/6 monomers and -2 heterodimer inhibit enterovirus 71 replication by activating the antiviral innate response. Sun PP; Li D; Su M; Ren Q; Guo WP; Wang JL; Du LY; Xie GC Front Immunol; 2023; 14():1187035. PubMed ID: 37207203 [TBL] [Abstract][Full Text] [Related]
19. DNA vaccine against the non-structural 1 protein (NS1) of dengue 2 virus. Costa SM; Freire MS; Alves AM Vaccine; 2006 May; 24(21):4562-4. PubMed ID: 16140430 [TBL] [Abstract][Full Text] [Related]
20. The inflammasome pathway is activated by dengue virus non-structural protein 1 and is protective during dengue virus infection. Wong MP; Juan EYW; Pahmeier F; Chelluri SS; Wang P; Castillo-Rojas B; Blanc SF; Biering SB; Vance RE; Harris E PLoS Pathog; 2024 Apr; 20(4):e1012167. PubMed ID: 38662771 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]